We are a biotech company active in the field of cellular therapies, specializing in the collection, preparation, characterization, processing and storage of stem cells and tissues for therapeutic use or for the development of new experimental protocols. We place great emphasis on scrupulously following the guidelines of international bodies developed for the field of cell therapy. Our focus allows us to guarantee highly stable products of high quality, traceability and scientific rigor.
In our laboratories, we are engaged in processing cord blood, cord tissue, placental tissue and amniotic membrane for stem cell extraction, quality control and sample storage. Our bio-bank has the capacity to cryopreserve a wide range of biological materials:
- Umbilical cord blood stem cells
- Umbilical cord tissue stem cells
- Placental tissue stem cells
- Amniotic membrane
- Peripheral blood
- Plasma and serum
Cryopreservation of cells is carried out in nitrogen vapor as a guarantee of their quality and maximum safety.
FamiCord Suisse - Why choose us
The production laboratory operates 7 days a week - 365 days a year to ensure high process quality for all samples received.
Continuous monitoring of the storage tanks with direct connection to the technical staff in case of need.
The quality control laboratory performs the complete characterization of the processed and released samples using various technologies (microscopy, PCR, cytofluorimetry, microbiology, proficiency testing, etc.) and issues the corresponding certificates of analysis.
Dank eines Qualitätssystems, das auf der Einhaltung der neuesten nationalen und internationalen Richtlinien basiert, gewährleisten wir eine vollständige Rückverfolgbarkeit der in unseren Labors bearbeiteten Proben und der Kontrollfunktionen der Biobank.
To promote quality and safety in processing and preservation techniques, FamiCord employs highly qualified personnel (according to industry standards).
The scientific management is highly qualified:
Our medical director, is a highly experienced hematologist with more than 25 years of experience in the field of oncology and stem cell transplantation. His experience is evidenced by hundreds of scientific publications and presentations at top international congresses.
Our QP and QA, are highly specialized in Good Manufacturing Practice and Good Distribution Practice.
Our Scientific Director, who also holds a Masters in Advanced Therapies Medicinal Products (ATMP) manufacturing, is fundamental to the development of protocols for regenerative medicine.
Research and development
In our R&D department we work:
- Develop protocols for the derivation of stem cells from various sources
- Develop protocols for long-term storage of stem cells
- Implement the R&D protocols in the GMP laboratory
- Work with the rest of the FamiCord group on internationally recognized clinical trials and develop production and preparation of cells for transplantation.
Thanks to our experience, we have provided consultations for enrollment in international clinical trials. Our scientific director has helped enroll more than 60 children with cerebral palsy in the internationally recognized protocols.